Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Annexon Biosciences (ANNX)
NASDAQ:ANNX
Annexon Biosciences (ANNX) Ownership - Who Owns Annexon Biosciences?
787 Followers
Annexon Biosciences (ANNX) Ownership Overview
18.68% Insiders
17.86% Mutual Funds
8.55% Other Institutional Investors
54.90% Public Companies and Individual Investors
The ownership structure of Annexon Biosciences (ANNX) stock is a mix of institutional, retail and individual investors. Approximately 26.41% of the company’s stock is owned by Institutional Investors, 18.68% is owned by Insiders and 54.90% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 17, 2024 | Ted Yednock Evp & Chief Innovation Officer | xxxxxxxxxxxxx | $6658 |
| Feb 21, 2024 | Jennifer Lew Evp & Cfo | xxxxxxxxxxxxx | $14339 |
| Feb 21, 2024 | Michael Overdorf Evp & Chief Business Officer | xxxxxxxxxxxxx | $10691 |
| Feb 21, 2024 | Ted Yednock Evp & Chief Innovation Officer | xxxxxxxxxxxxx | $14348 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $97641 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $14344366 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $18968407 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,386,223 | Institution | 4.16% | 24,694,435 | |
| 3,361,984 | Institution | 3.19% | 18,927,970 | |
| 3,297,963 | Institution | 3.13% | 18,567,532 | |
| 2,877,657 | Institution | 2.73% | 16,201,209 | |
| 2,814,168 | Institution | 2.67% | 15,843,766 | |
| 2,645,524 | Institution | 2.51% | 14,894,300 | |
| 2,000,609 | Institution | 1.90% | 11,263,429 | |
| 1,867,250 | Institution | 1.77% | 10,512,618 | |
| 1,830,597 | Institution | 1.74% | 10,306,261 | |
| 1,315,548 | Institution | 1.25% | 7,406,535 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,297,963 | Institution | 3.13% | 18,567,532 | |
| 2,877,657 | Institution | 2.73% | 16,201,209 | |
| 2,814,168 | Institution | 2.67% | 15,843,766 | |
| 1,867,250 | Institution | 1.77% | 10,512,618 | |
| 1,830,597 | Institution | 1.74% | 10,306,261 | |
| 1,315,548 | Institution | 1.25% | 7,406,535 | |
| 774,638 | Institution | 0.73% | 4,361,212 | |
| 723,791 | Institution | 0.69% | 4,074,943 | |
| 696,433 | Institution | 0.66% | 3,920,918 | |
| 649,218 | Institution | 0.62% | 3,655,097 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,829,766 | Institution | 2.68% | 13,865,853 | |
| 2,241,544 | Institution | 2.13% | 12,619,893 | |
| 1,040,148 | Institution | 0.99% | 5,096,725 | |
| 786,697 | Institution | 0.75% | 4,429,104 | |
| 313,600 | Institution | 0.30% | 1,536,640 | |
| 238,574 | Institution | 0.23% | 1,333,629 | |
| 189,568 | Institution | 0.18% | 1,067,268 | |
| 130,050 | Institution | 0.12% | 726,980 | |
| 115,384 | Institution | 0.11% | 649,612 | |
| 126,812 | Institution | 0.12% | 649,454 |
FAQ
Who Owns Annexon Biosciences (ANNX)?
According to the latest TipRanks data, approximately 8.55% of the company's stock is held by institutional investors, 18.68% is held by insiders, and 54.90% is held by retail investors.
What percentage of Annexon Biosciences (ANNX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 8.55% of Annexon Biosciences (ANNX) stock is held by institutional investors.
What percentage of Annexon Biosciences (ANNX) stock is held by retail investors?
According to the latest TipRanks data, approximately 54.90% of Annexon Biosciences (ANNX) stock is held by retail investors.
Who owns the most shares of Annexon Biosciences (ANNX)?
Vanguard owns the most shares of Annexon Biosciences (ANNX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.